Location History:
- Daejeon, KR (2018)
- Sejong, KR (2020)
Company Filing History:
Years Active: 2018-2020
Title: Seil Jang: Innovator in Cancer Immunotherapy
Introduction
Seil Jang is a prominent inventor based in Sejong, South Korea. He has made significant contributions to the field of cancer immunotherapy, holding a total of 5 patents. His work focuses on developing innovative binding molecules that can enhance the effectiveness of cancer treatments.
Latest Patents
One of Seil Jang's latest patents involves cell engaging binding molecules. This patent is broadly concerned with the field of cancer immunotherapy. The binding molecule comprises antibody variable light (VL) regions, variable heavy (VH) regions, constant heavy 1 (CH1) regions, and light chain constant (CL) regions. These components are configured to form two antigen binding Fab regions and an antigen binding Fv region, allowing the binding molecule to bind to two different antigens. This innovative approach has the potential to improve therapeutic outcomes for cancer patients.
Career Highlights
Throughout his career, Seil Jang has worked with notable companies such as Y-Biologics Inc. and Metabolic Engineering Laboratories Co., Ltd. His experience in these organizations has contributed to his expertise in the development of advanced therapeutic solutions.
Collaborations
Seil Jang has collaborated with several professionals in his field, including Bum-chan Park and Young Woo Park. These collaborations have fostered a productive environment for innovation and research in cancer immunotherapy.
Conclusion
Seil Jang is a dedicated inventor whose work in cancer immunotherapy is paving the way for new treatment options. His innovative binding molecules represent a significant advancement in the fight against cancer.